Company Overview and News

 
Merger Arbitrage In One Place (Part 4) - Deals Of The East

2018-09-18 seekingalpha
This is the fourth and the last part of the currently followed deals, which contain situations of the Eastern part of our globe. Following posts are going to include news and updates on the deals + news deals and rumors whenever possible. For the first part and more details on the series please check here.
BGCHY CPQHF LUNMF BGA LUNCF CZZ DUETF LUN DUE

 
Beekeepers support Capilano takeover bid

2018-09-13 businessnews.com.au
The beekeeper-owners of Capilano Honey have thrown their support behind a private equity takeover bid for the Australian company.
CPQHF CZZ

 
Bega Cheese has taste for growth with plans to raise $250 million

2018-09-10 theage.com.au
The fast-growing and ambitious dairy and food company Bega Cheese is seeking to raise about $250 million as it beds down its recent expansion in western Victoria, after it bought one of Australia's biggest dairy processing facilities.
BGCHY CPQHF BGA CZZ

 
Horticulturalist insists honey testing was to protect local industry

2018-09-10 theage.com.au
Horticulturalist Robert Costa has stressed the only reason he commissioned controversial testing of honey purity was to protect the Australian industry.
BGCHY CPQHF BGA CZZ

 
CBD: Chinese whispers in Canberra press gallery

2018-09-10 smh.com.au
Over the years the Canberra Press Gallery has been home to all personality types, from the mad to the bad, and even one (current) reporter who appeared with Dame Joan Sutherland in the Donizetti opera Lucia di Lammermoor.
BGCHY GJV CPQHF NWS NWSA BGA CZZ

 
Bega Cheese has taste for growth with plans to raise $250 million

2018-09-10 smh.com.au
The fast-growing and ambitious dairy and food company Bega Cheese is seeking to raise about $250 million as it beds down its recent expansion in western Victoria, after it bought one of Australia's biggest dairy processing facilities.
BGCHY CPQHF BGA CZZ

 
Horticulturalist insists honey testing was to protect local industry

2018-09-10 smh.com.au
Horticulturalist Robert Costa has stressed the only reason he commissioned controversial testing of honey purity was to protect the Australian industry.
BGCHY CPQHF BGA CZZ

 
Capilano changes tune on honey testing with offer to fund lab

2018-09-05 smh.com.au
Capilano, the nation's largest honey producer, has changed its tune on a testing method that has shown some of its products were impure, and now wants to fund a lab to carry out the tests in Australia.
CPQHF CZZ

 
Capilano changes tune on honey testing with offer to fund lab

2018-09-05 theage.com.au
Capilano, the nation's largest honey producer, has changed its tune on a testing method that has shown some of its products were impure, and now wants to fund a lab to carry out the tests in Australia.
CPQHF CZZ

 
New purity test on the cards amid honey 'adulteration' scandal

2018-09-03 theage.com.au
Honey shipped to Australia could face a new test to weed out "fake" produce under changes being considered by the federal government as the Labor opposition has called from a new regime to be swiftly introduced to protect the honey industry's integrity.
CPQHF CZZ

 
New purity test on the cards amid honey 'adulteration' scandal

2018-09-03 smh.com.au
Honey shipped to Australia could face a new test to weed out "fake" produce under changes being considered by the federal government as the Labor opposition has called from a new regime to be swiftly introduced to protect the honey industry's integrity.
CPQHF CZZ

7
Deals of the day-Mergers and acquisitions

2018-08-13 reuters - 1
Aug 13 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Monday:
APA CPQHF NLSN CZZ APA

 
Capilano Honey looks to tap Chinese demand in $200m deal

2018-08-13 theage.com.au
Australia's best-known honey brand Capilano is hoping to tap into the huge Chinese market after announcing a proposed $200 million deal with a private equity firm.
CPQHF CZZ

 
Capilano Honey looks to tap Chinese demand in $200m deal

2018-08-13 smh.com.au
Australia's best-known honey brand Capilano is hoping to tap into the huge Chinese market after announcing a proposed $200 million deal with a private equity firm.
CPQHF CZZ

2
ASX slides as Turkey tremors take hold

2018-08-13 theage.com.au
Australian shares fell on Monday, joining in with losses for stock markets across Asia, as investors fretted that a slide in the Turkish lira could herald the start of a broader market rout.
CPQHF RIO BLT RIO BHPBF RTPPF BHP RIO RTNTF BBL BHP CZZ BHPLF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CZZ / CAPILANO HONEY LIMITED on message board site Silicon Investor.

CZZ CZZ CZZ